Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperidine and azetidine derivatives as GlyT1 inhibitors

Piperidine and azetidine derivatives as GlyT1 inhibitors

US Patent 7655644 · Granted Feb 2, 2010

Estimated economic value: $130,144,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

METTL3 inhibitory compounds2025
Inhibitors of receptor interacting protein kinase I for the treatment of disease2025
Polyheterocyclic compounds as METTL3 inhibitors2025
GLS1 inhibitors for treating disease2024
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
Polyheterocyclic compounds as METTL3 inhibitors2023
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
GLS1 inhibitors for treating disease2023
Inhibitors of receptor interacting protein kinase I for the treatment of disease2023
ATM kinase inhibitors and compositions and methods of use thereof2023
GLS1 inhibitors for treating disease2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the2022